The impact of luteal phase support on endometrial estrogen and progesterone receptor expression: a randomized control trial

• Main Authors: Brezina Paul R (Author), Vlahos Nikos F (Author), Lai Tsung-Hsuan (Author), Garcia Jairo E (Author), Wallach Edward E (Author), Zhao Yulian (Author)
• Format: Book
• Published: BMC, 2012-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.1186/1477-7827-10-16; 1477-7827
• Keywords: ERα; ER alpha; Endometrium; "Controlled ovarian hyperstimulation"; Gynecology and obstetrics; RG1-991; Reproduction; QH471-489
• Source: Reproductive Biology and Endocrinology, Vol 10, Iss 1, p 16 (2012)

<p>Abstract</p> <p>Background</p> <p>To assess the impact of luteal phase support on the expression of estrogen receptor (ER) alpha and progesterone receptors B (PR-B) on the endometrium of oocyte donors undergoing controlled ovarian hyperstimulation (COH).</p> <p>Methods</p> <p>A prospective, randomized study was conducted in women undergoing controlled ovarian hyperstimulation for oocyte donation. Participants were randomized to receive no luteal support, vaginal progesterone alone, or vaginal progesterone plus orally administered 17 Beta estradiol. Endometrial biopsies were obtained at 4 time points in the luteal phase and evaluated by tissue microarray for expression of ER alpha and PR-B.</p> <p>Results</p> <p>One-hundred and eight endometrial tissue samples were obtained from 12 patients. No differences were found in expression of ER alpha and PR-B among all the specimens with the exception of one sample value.</p> <p>Conclusions</p> <p>The administration of progesterone during the luteal phase of COH for oocyte donor cycles, either with or without estrogen, does not significantly affect the endometrial expression of ER alpha and PR.</p>